EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fluconazole Safety in Pediatric Practice: A Critical Narrative Review of Developmental Pharmacology, Adverse Reactions, and Clinical Monitoring

Jelena Krdzic Milovanovic, Marija Jevtic, Samir Vucelj, Bojana Bozic Cvijan, Edin Karisik, Azra Kucevic Kalac, Bilsena Kurtanovic Masovic, Semira Osmanlic, Meliha Lekovic, Mersiha Mulic, Esin Halo, Dina Dolovac

Children · 14.11.2026 · 13 (11) · 1587

DOI: 10.3390/children13111587 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Children, online erschienen am 14.11.2026. Verfasst von Jelena Krdzic Milovanovic und 11 weiteren Autor:innen. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fluconazole has an important role in the prevention and treatment of selected fungal infections in children, but assessment of its safety requires consideration of developmental stage, treatment indication, organ function, concomitant medications, and the anticipated fungal pathogen. This critical narrative review integrates pediatric evidence on developmental pharmacokinetics, clinical tolerability, hepatotoxicity, QT-interval prolongation, other clinically significant adverse reactions, drug interactions, antifungal stewardship, and risk-directed monitoring. Relevant evidence was identified through targeted literature searches and appraisal of pediatric clinical studies, pharmacokinetic investigations, systematic reviews, meta-analyses, clinical guidelines, and regulatory sources. Evidence was interpreted according to study design, directness to the pediatric population and indication, consistency, precision, and susceptibility to confounding. The strongest comparative pediatric evidence concerns prophylaxis in high-risk preterm neonates, whereas direct evidence for treatment of invasive neonatal candidiasis remains substantially more limited. Gastrointestinal adverse reactions and abnormalities in liver biochemical tests are among the most consistently reported findings, but laboratory abnormalities should not be equated with clinically significant drug-induced liver injury. Pediatric evidence confirms the possibility of serious cardiac and cutaneous reactions but does not permit reliable estimation of their incidence. Evidence regarding the vincristine interaction is heterogeneous, whereas pharmacokinetic evidence more directly supports clinically important changes in tacrolimus exposure. Antifungal susceptibility, previous azole exposure, local resistance patterns, and the required antifungal spectrum also influence the overall benefit–risk assessment. Available evidence therefore supports individualized prescribing and monitoring based on developmental pharmacokinetics, organ function, clinical indication, concomitant therapy, and established patient-specific risk factors, while avoiding assumptions of age- or exposure-dependent toxicity that are not supported by comparative pediatric data.

Zitieren

APA

Milovanovic, J. K., Jevtic, M., Vucelj, S., Cvijan, B. B., Karisik, E., Kalac, A. K., Masovic, B. K., Osmanlic, S., Lekovic, M., Mulic, M., Halo, E., & Dolovac, D. (2026). Fluconazole Safety in Pediatric Practice: A Critical Narrative Review of Developmental Pharmacology, Adverse Reactions, and Clinical Monitoring. Children, 13(11), 1587. https://doi.org/10.3390/children13111587

Vancouver

Milovanovic JK, Jevtic M, Vucelj S, Cvijan BB, Karisik E, Kalac AK, et al. Fluconazole Safety in Pediatric Practice: A Critical Narrative Review of Developmental Pharmacology, Adverse Reactions, and Clinical Monitoring. Children. 2026;13(11):1587. doi:10.3390/children13111587

BibTeX
@article{Milovanovic2026,
  author = {Milovanovic, Jelena Krdzic and Jevtic, Marija and Vucelj, Samir and Cvijan, Bojana Bozic and Karisik, Edin and Kalac, Azra Kucevic and Masovic, Bilsena Kurtanovic and Osmanlic, Semira and Lekovic, Meliha and Mulic, Mersiha and Halo, Esin and Dolovac, Dina},
  title = {Fluconazole Safety in Pediatric Practice: A Critical Narrative Review of Developmental Pharmacology, Adverse Reactions, and Clinical Monitoring},
  journal = {Children},
  year = {2026},
  volume = {13},
  number = {11},
  pages = {1587},
  doi = {10.3390/children13111587}
}
Kostenlos starten →